Vaishali Pharma Ltd (VAISHALI) is currently trading at 8.14 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Vaishali Pharma Limited is a pharmaceutical company that deals in formulations, APIs, surgical products, veterinary supplements, and nutraceutical products. The company operates in both domestic and international markets, focusing on API trading locally and marketing a broader range of products abroad. The company has established a strong international presence with over 250 formulation brands across various countries, showcasing a diversified product pipeline and strategic manufacturing collaborations. Vaishali Pharma was recognized as a 'One Star Export House' by the Government of India in 2017, highlighting its export capabilities and significance in international trade. The company holds multiple quality certifications, including ISO 9001:2015, and is linked with certified manufacturing facilities, ensuring high compliance with global standards. Vaishali Pharma's growth includes the launch of a surgical division and venturing into formulation manufacturing and exports, emphasizing its strategic expansion and diversification into new markets and product lines.

Over the past 52 weeks, Vaishali Pharma Ltd has traded between a low of ₹4.75 and a high of ₹12.70. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Vaishali Pharma Ltd has a market capitalization of approximately 108.81. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Vaishali Pharma Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 25.66 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 108.81 Cr, Vaishali Pharma Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Vaishali Pharma Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Vaishali Pharma Ltd is 25.66. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.